Option Care Health (OPCH) PT Raised to $38 at Jefferies

Jefferies analyst Brian Tanquilut raised the price target on Option Care Health (NASDAQ: OPCH) to $38.00 (from $36.00) while maintaining a Buy rating.

The analyst comments "We maintain our Buy on OPCH given our belief that the company's robust growth outlook and likely earnings upside surprises are not fully reflected in the stock's valuation. While OPCH's reported Q4 and initial FY24 financial guidance are what we typically expect of the company -- slight beats every quarter, conservative guidance -- we see EBITDA growth acceleration in '25, share buybacks, and potential M&A as drivers of share upside over the next 12-18 mos."

You May Also Be Interested In

• Coherent (COHR) PT Raised to $420 at Needham
• Unicycive Therapeutics (UNCY) PT Lowered to $25 at Guggenheim
• Cytokinetics (CYTK) PT Raised to $110 at Barclays